Nomax Inc: Drug Recall

Recall #D-0463-2024 · 04/19/2024

Class II: Risk

Recall Details

Recall Number: D-0463-2024
Classification: Class II
Product Type: Drug
Recalling Firm: Nomax Inc
Status: Ongoing
Date Initiated: 04/19/2024
Location: Saint Louis, MO, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 6,960 cartons

Reason for Recall

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Product Description

GloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Only, 100 Sterile Strips per carton, Nomax, Inc., St. Louis, MO 63123, NDC 51801-009-40.

Distribution Pattern

Nationwide in the USA

Other Recalls by Nomax Inc

Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class III: Low Risk 04/13/2021

Subpotent Drug

View all recalls by Nomax Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.